Market May Have Turned the Corner

It’s been a solid two weeks for the market. Both our Cabot Tides (intermediate-term trend) and Two-Second Indicator (health of the broad market) are now positive. This is the first time both have been green for a few months, and it’s definitely an encouraging sign that the market may have turned the corner.

That said, there are still headwinds out there. Our Cabot Trend Lines (longer-term trend) remain negative, and few stocks are hitting new highs (fewer than 40 nearly every day on the Nasdaq, for instance). Not that we need to see 200 stocks hitting new highs before turning bullish, but there’s a definite lack of leadership, especially among growth stocks.

The real question on everyone’s mind is whether the rally of the past three weeks has put in a sustained bottom to this multi-month correction, or whether this rebound is more like the October-November upmove, which led to another leg down.

If forced to choose, we’d favor the “bottom is in” scenario, based on the extremes we saw in late-January/early-February in breadth and sentiment, and the improvement in the broad market—we’ve finally seen the beaten-down groups build some decent-looking bottoms and thrust higher in a significant way. (Getting the worst groups to find a low is important for overall market health.)

As usual, though, what counts to us most aren’t predictions but current conditions. Right now, we’ve seen enough evidence to begin putting money to work, but we haven’t seen enough to continue the buying spree. We’re looking for more individual growth stocks to lift off to “pull” us into a more heavily invested position, along with further market strength.

This is an excerpt from Cabot Growth Investor, where we’ve been picking the best growth stocks since 1970. Cabot’s flagship advisory combines expert stock selection and award-winning market timing. It’s the most complete and most helpful, growth-oriented investing advisory available anywhere.

Michael Cintolo is Cabot's Vice President of Investments and Chief Analyst of Cabot Growth Investor and Cabot Top Ten Trader. To read customer reviews of Cabot Top Ten Trader, click here. To read reviews of Cabot Growth Investor, click here.

Michael Cintolo can be found on Google Plus.

Stock Picks


This stock could rise 50% before becoming fairly valued.

This hot technology company is growing like a weed, thanks to products that speed up cloud communications.

This stock is somewhat well known, but far from well loved.

Cabot Wealth Advisory

Buy This Small-Cap Tech Stock as the Nasdaq Thrives

By Tyler Laundon on October 20, 2016

Technology stocks are thriving, as the Nasdaq has been outpacing the S&P 500 and the Dow for months. And one small-cap tech stock in particular is outperforming the industry’s big boys. Read More >

Is Allergan (AGN) Still an Undervalued Stock?

By Crista Huff on October 18, 2016

Five months ago, Allergan (AGN) was an undervalued stock with tons of growth potential. It's up 21% since then, but still has plenty of upside. Here's why.Read More >

Diversify with Canadian Stocks

By Timothy Lutts on October 17, 2016

Canadian stocks are a good way to diversify your portfolio without taking on too much risk. And one Canadian stock in particular looks quite undervalued.Read More >